Document Type

Article

Publication Date

March 2025

Patent Number

12257248

CPC

A61K 31/4745

Abstract

Disclosed herein are compounds useful for treating obstructive lung diseases. The compounds are TAS2Rs agonists and may further be used to treat disorders and conditions implicated by TAS2R. In some instances the disclosed compounds can be used to treat asthma.

Application Number

17/464233

Assignees

University of South Florida

Filing Date

09/01/2021

Share

COinS